What would happen?
First of all, this could happen. The molecule has been nominated, which was an internal corporate event. Investor relations (Kendra) has also been clear that they would share the profile of the molecule at an appropriate public event. So go figure.
- God Molecule nominated. Check.
- Biggest healthcare conference of the year is happening next week. Check.
There isn't a better time to unveil The God Molecule. And when they do, and if it is good, it will be an extremely interesting day. Big Institutional investors will want in. Shorts will be trapped at the exit. And the outcome could conceivably be a 100% plus increase in share price.
UPDATE: I wrote to Kendra at investor Relations and asked her to confirm if the internal nomination for the new molecule happened. Her reply was that "She encourages that [we] listen to the webcast at the JP Morgan conference for a full update."
UPDATE: I wrote to Kendra at investor Relations and asked her to confirm if the internal nomination for the new molecule happened. Her reply was that "She encourages that [we] listen to the webcast at the JP Morgan conference for a full update."
This is not a good time to sell.
Good luck to all.
TC
I said weeks ago it would be at the conference..Good Luck to the short worms when we get that big buyer to step up.BlackRock better take advantage of that exemption or give it to Denner.
ReplyDelete